Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 277-785-3 | CAS number: 74239-96-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- other company data
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Guideline 442E (In Vitro Skin Sensitisation assays addressing the Key Event on activation of dendritic cells on the Adverse Outcome pathway for Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- The 2-mercaptoethanol was not used in the culture medium because this toxic compound is not necessary for the culture of THP-1
- GLP compliance:
- yes
- Type of study:
- activation of dendritic cells
Test material
- Reference substance name:
- Disperse Blue 354
- IUPAC Name:
- Disperse Blue 354
- Test material form:
- solid: particulate/powder
Constituent 1
In vitro test system
- Details on the study design:
- DMSO (Dimethysulfoxide) was used as an intermediate solvent.
Concentration range: 3.91 to 500 µg/ml
METHODS
Preliminary study: Cytotoxicity assays
The cytotoxicity of the test item was evaluated in order to select at least 4-5 concentrations able to induce cytotoxicity, around 50%, for the highest one. Assessment of cell toxicity was performed by determining cell viability on THP-1 cells, using the 7-AAD inclusion methods.
Eight concentrations of test item have been prepared by a two-fold serial dilution from a maximum final concentration of 1000 µg/mL or lower, depending on its solubility limit.
In the day of testing, cells harvested from culture flask were suspended with fresh culture medium at 2 x 10‸6 cells/mL. Then, THP-1 cells were distributed into a 24 well flat-bottom plate with 500 µL (1 x 10‸6 cells/well) with various concentrations of test item (1 :1 ratio) for 24 ± 0.5 hours at 37 °C under 5 % CO2. After treatment cells were washed twice with phosphate-buffered containing 0.1% (w/v) bovine serum albumin identified as FACS buffer (Fb). The cells were stained with 7-AAD (5 µg/mL final concentration). Then cells were analysed with flow cytometry using GUAVA (Merck Millipore, France) and lnCyte software to measure cell viability. The living cells (7-AAD) gate was set in the 7-AAD negative area. 104 7-AAD- cells were counted as the living population.
According to the results the dose levels for the main study were selected.
Main study: Activation test
Based on the cytotoxicity assay the eight final test item concentrations were selected. In case of non-toxic concentration for the top dose used in preliminary test, the maximum concentration selected for activation test did not exceed 1000 µg/mL when the test item was dissolved or stably dispersed in Ethanol or DMSO, and 5000 µg/mL when the test item was dissolved in a saline vehicle. The range of concentrations has been adjusted for activation test 2 and 3 (if necessary) depending on results obtained in previous experiments, to calculate the minimum induction threshold. Each experiment of activation test was performed on eight concentrations.
THP-1 cells were plated at 1*106 cells/mL/well in 24 well plates and treated for 24 ± 0.5 hours with selected test item concentrations. After treatment cells were washed twice with Fb. Then cells were stained for 30 min at 4°C with the following fluorescein isothiocyanate (FITC) conjugated monoclonal antibodies (mAbs): anti-human CD54, anti-human CD86; FITC labelled-mouse lgG1. Using the manufacturer's recommended dilutions, cells were incubated with above mAbS at 6 µL/3x10‸5 cells /50 µL for the anti-human CD86 mAb, and 3 µL/3x105 cells /50 µL for the anti—human CD54 mAb. FITC labelled-mouse IgG1 was used as an isotype control at a dilution of 3 µL/3x10‸5 cells /50 µL. Then, the cells were stained also with 7—AAD for 30 min at 4°C. After washing and resuspension with Fb, the fluorescence intensities of the THP-1 cell surface markers were then analysed by flow cytometry using GUAVA (Merck Millipore, France) and lnCyte software, on 10000 living cells.
Validation of the study
Acceptability criteria for evaluating results induced by the positive control, the vehicles controls and the test item, were based on previous studies cited above and the guideline for h-CLAT (OECD442E, 2016).
This study is considered valid if the following criteria are fully met:
- In the positive control (DNCB):
RFI values of both CD86 and CD54 should be over the positive criteria (CD54 ≥ 200% and CD86 ≥ 150%).
The cell viability Should be more than 50%
- In the vehicle control (medium, 0.9% NaCl, DMSO, Ethanol etc):
Cell viability Should be more than 90%
In the solvent/vehicle control, RFI values of both CD86 and CD54 should not exceed the positive criteria (CD86 ≥ 150% and CD54 ≥ 200%) compared to the medium control.
The MFI ratio of both CD86 and CD54 to isotype control should be > 105%
- In the test item:
Cell viability should be more than 50% in at least four tested concentrations in each run.
Results and discussion
In vitro / in chemico
Results
- Run / experiment:
- other: mean of two runs
- Parameter:
- other: Minimum induction threshold (MIT)
- Value:
- 79.6
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- positive indication of skin sensitisation
Any other information on results incl. tables
Concentration range* | Viability | CD54 | CD86 | MIT (μg/ml) | |
Run 1 | 3.91 to 500 μg/ml | > 50 % | RFI > 200 | RFI < 150 | 79.6 |
Run 2 | > 50 % | RFI > 200 | RFI < 150 |
Applicant's summary and conclusion
- Interpretation of results:
- other: Skin sensitizer
- Remarks:
- according to the criteria set up on the OECD guideline 442E
- Conclusions:
- Skin sensitising
- Executive summary:
The test substance was evaluated for its potential to induce skin sensitisation according to the procedure described in the OECD gudeline 442E.
No cytotoxicity was induced on THP-1 cells by the test item. In the assay conditions, a reproducible "increase" of the CD54 expression compared with the negative control at least for two dose-levels of Disperse Blue 354 was noticed.
In the first experiment, a dose-response relationship was noticed only for CD54 marker with an increase of 2.01 to 14.5 fold of expression compared to the negative control.
In the second experiment, a dose-response relationship was also observed for the CD54 marker with an increase of 6.12 to 7.77 fold of expression compared to the negative control. A Slight increase of expression for CD86 marker (fold increase 1.58) was only observed for one close, but without no-dose effect.
Conclusion
Based on these results, the test item demonstrated an in vitro sensitizing potential with a Minimum Induction Threshold (MIT) of 79.6 µg/mL (in active substance) in condition of the experimental human Cell Line Activation Test, during this study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.